NDC 73090-421

Sylvant

Siltuximab

Sylvant is a Intravenous Injection, Powder, For Solution in the Human Prescription Drug category. It is labeled and distributed by Eusa Pharma (uk) Ltd. The primary component is Siltuximab.

• Product ID: 73090-421_55f7afac-941e-48b7-8477-9478b550ad75
• NDC: 73090-421
• Product Type: Human Prescription Drug
• Proprietary Name: Sylvant
• Generic Name: Siltuximab
• Dosage Form: Injection, Powder, For Solution
• Route of Administration: INTRAVENOUS
• Marketing Start Date: 2014-04-23
• Marketing Category: BLA / BLA
• Application Number: BLA125496
• Labeler Name: EUSA Pharma (UK) Ltd
• Substance Name: SILTUXIMAB
• Active Ingredient Strength: 400 mg/1
• Pharm Classes: Interleukin-6 Antagonist [EPC], Interleukin-6 Antagonists [MoA]
• NDC Exclude Flag: N
• Listing Certified Through: 2023-12-31

Packaging

NDC 73090-421-01

1 VIAL, SINGLE-DOSE in 1 BOX (73090-421-01) > 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE

• Marketing Start Date: 2014-04-23
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 73090-421-01 [73090042101]

Sylvant INJECTION, POWDER, FOR SOLUTION

• Marketing Category: BLA
• Application Number: BLA125496
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 2014-04-23

Drug Details

Active Ingredients

Ingredient	Strength
SILTUXIMAB	400 mg/1

OpenFDA Data

• SPL SET ID: 8d663642-f52e-49c0-a023-2da083fdfc0b
• Manufacturer:
  • EUSA Pharma (UK) Ltd
• UNII:
  • T4H8FMA7IM

Pharmacological Class

• Interleukin-6 Antagonist [EPC]
• Interleukin-6 Antagonists [MoA]

NDC Crossover Matching brand name "Sylvant" or generic name "Siltuximab"

NDC	Brand Name	Generic Name
57894-420	SYLVANT	siltuximab
57894-421	SYLVANT	siltuximab
73090-420	Sylvant	Siltuximab
73090-421	Sylvant	Siltuximab